國立虎尾科技大學 |

Drug wars = how big pharma raises prices and keeps generics off the market /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Drug wars/ Robin Feldman, Evan Frondorf.
其他題名:	how big pharma raises prices and keeps generics off the market /
作者:	Feldman, Robin.
其他作者:	Frondorf, Evan.
出版者:	Cambridge :Cambridge University Press, : 2017.,
面頁冊數:	xii, 151 p. :digital ; : 24 cm.;
附註:	Title from publisher's bibliographic system (viewed on 17 Jul 2017).
標題:	Drugs - Prices - United States. -
電子資源:	https://doi.org/10.1017/9781316717424
ISBN:	9781316717424

Drug wars = how big pharma raises prices and keeps generics off the market /
Feldman, Robin.

Drug warshow big pharma raises prices and keeps generics off the market /[electronic resource] :Robin Feldman, Evan Frondorf. - Cambridge :Cambridge University Press,2017. - xii, 151 p. :digital ;24 cm.

Title from publisher's bibliographic system (viewed on 17 Jul 2017).

Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform.

While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.

ISBN: 9781316717424Subjects--Topical Terms:

1029752
Drugs
--Prices--United States.

LC Class. No.: RA401.A3 / F45 2017

Dewey Class. No.: 338.476151

Drug wars = how big pharma raises prices and keeps generics off the market /
LDR:02218nam a2200265 a 4500 001 1001109
003 UkCbUP
005 20170814135646.0
006 m d
007 cr nn 008maaau
008 201228s2017 enk o 1 0 eng d
020 $a 9781316717424 $q (electronic bk.)
020 $a 9781107168480 $q (paper)
035 $a CR9781316717424
040 $a UkCbUP $b eng $c UkCbUP $d GP
041 0 $a eng
050 4 $a RA401.A3 $b F45 2017
082 0 4 $a 338.476151 $2 23
090 $a RA401.A3 $b F312 2017
100 1 $a Feldman, Robin. $3 1003311
245 1 0 $a Drug wars $h [electronic resource] : $b how big pharma raises prices and keeps generics off the market / $c Robin Feldman, Evan Frondorf.
260 $a Cambridge : $b Cambridge University Press, $c 2017.
300 $a xii, 151 p. : $b digital ; $c 24 cm.
500 $a Title from publisher's bibliographic system (viewed on 17 Jul 2017).
505 8 $a Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform.
520 $a While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.
650 0 $a Drugs $x Prices $z United States. $3 1029752
650 0 $a Drugs $x Law and legislation $z United States. $3 570576
650 0 $a Pharmaceutical policy $z United States. $3 1005584
650 0 $a Pharmaceutical industry $z United States. $3 583249
650 0 $a Generic drugs $z United States. $3 1294173
700 1 $a Frondorf, Evan. $3 1294172
856 4 0 $u https://doi.org/10.1017/9781316717424